As per MRFR analysis, the US Atherectomy Devices Market Size was estimated at 409.15 (USD Million) in 2023. The US Atherectomy Devices Market Industry is expected to grow from 428.65(USD Million) in 2024 to 700.17 (USD Million) by 2035. The US Atherectomy Devices Market CAGR (growth rate) is expected to be around 4.562% during the forecast period (2025 - 2035).
The US Atherectomy Devices Market is experiencing several important trends shaped by advancements in technology and increasing healthcare awareness. One key market driver is the rising incidence of cardiovascular diseases, which has led to a significant demand for minimally invasive surgical techniques. The US healthcare system is increasingly focusing on patient comfort and quick recovery, which promotes the growth of atherectomy devices that offer such benefits. With the aging population in the US, there is a growing need for effective treatment options for peripheral artery diseases, which is further propelling market growth.
Recent innovations in atherectomy technology, including the development of more precise and safer devices, have emerged as a vital trend. Physicians are now able to use devices that provide enhanced visualization and control during procedures, significantly improving patient outcomes. In addition, there is an increased emphasis on clinical education, ensuring healthcare professionals are well-equipped to utilize these advanced devices properly. Opportunities for growth are also poised in the US market due to an increasing number of FDA-approved atherectomy devices, leading to more choices for healthcare providers and patients alike.
Furthermore, the shift towards value-based care in the US healthcare landscape emphasizes the importance of effective treatment methodologies that not only enhance patients' quality of life but also reduce long-term healthcare costs. The ongoing collaboration between manufacturers and healthcare institutions aims to address the emerging needs of the market, making atherectomy devices an essential part of cardiovascular treatment strategies in the US. As healthcare policies evolve, the focus on innovation and improved patient care will continue to shape the landscape of the US Atherectomy Devices Market.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The rising incidence of cardiovascular diseases is a significant driver for the growth of the US Atherectomy Devices Market Industry. According to the Centers for Disease Control and Prevention (CDC), about 697,000 people die from heart disease each year in the United States, representing one in every five deaths. Additionally, the American Heart Association reported that in 2020, approximately 18.2 million adults aged 20 and older had coronary artery disease, which necessitates surgical interventions, including atherectomy procedures.
The increasing need for effective treatment options, along with the introduction of innovative atherectomy devices by leading manufacturers such as Boston Scientific Corporation and Medtronic, is expected to contribute significantly to market growth. Furthermore, a gradual shift towards minimally invasive procedures enhances the demand for atherectomy tools, thereby boosting the overall market potential.
Technological innovations play a crucial role in expanding the US Atherectomy Devices Market Industry. The development of advanced atherectomy devices, such as laser atherectomy systems and rotational devices, enhances the efficacy and safety of procedures. For example, the US Food and Drug Administration (FDA) has been actively approving new atherectomy devices that improve patient outcomes and reduce complications. The Boston Scientific's Diamondback 360 and Spectranetics' Turbo-Tandem Catheter represent significant advancements that provide superior plaque removal capabilities.
These innovations not only increase the efficiency of procedures but also attract more healthcare providers to adopt these devices, further driving market growth.
The increasing geriatric population in the US is a notable driver for the US Atherectomy Devices Market Industry. The U.S. Census Bureau projects that by 2030, all baby boomers will be over the age of 65, creating a demographic shift leading to an increased prevalence of age-related diseases, specifically cardiovascular conditions. The National Council on Aging has indicated that two-thirds of older adults have multiple chronic conditions, a considerable factor that enhances the demand for atherectomy procedures.
This demographic trend underscores the need for efficient, innovative treatment solutions, making the atherectomy devices market increasingly relevant and essential for addressing the healthcare needs of the aging population.
Growing awareness regarding minimally invasive procedures significantly propels the US Atherectomy Devices Market Industry. As patient preferences shift towards less invasive surgical options due to shorter recovery times and reduced complications, healthcare providers are increasingly adopting atherectomy procedures. The American College of Cardiology notes that there has been a steady increase in the utilization of such procedures over the past decade.
Furthermore, during the COVID-19 pandemic, many patients delayed open surgical procedures, leading to increased interest and investment in less invasive techniques. This trend is encouraging medical professionals to promote atherectomy devices more, driven by advancements in technology and improved outcomes associated with these procedures.
The US Atherectomy Devices Market is characterized by a diverse range of types that cater to varying clinical needs in the treatment of arterial diseases. Each type of device has distinct functionalities and applications, contributing to specific treatment processes. Directional atherectomy devices are particularly noted for their capability to selectively remove plaque from arterial walls while preserving the healthy surrounding tissue, making them a favored choice among clinicians for treating lesions in peripheral arteries. Similarly, orbital atherectomy devices excel in treating calcified lesions by utilizing a unique grinding mechanism, effectively allowing for smoother arterial passage and improved blood flow.
The laser atherectomy devices have gained traction due to their precision in vaporizing plaque with minimal damage to surrounding structures, significantly improving procedural outcomes. Furthermore, rotational atherectomy devices play a vital role by offering the ability to treat complex lesions that are resistant to conventional balloon angioplasty, thereby enhancing the overall efficacy of revascularization procedures. The rising prevalence of cardiovascular diseases in the US continues to drive demand for these types of atherectomy devices. Furthermore, advancements in technology foster innovations, enabling better outcomes and expanding the indications for each type.
The regulatory environment also supports the introduction of innovative devices, further propelling overall market development. The significant growth potential within the US Atherectomy Devices Market indicates that each type will play an increasingly important role in addressing patient needs and improving overall cardiovascular health outcomes. The enhancement and differentiation in these device types reflect a broader trend toward personalized treatment options, which cater to individual patient anatomy and conditions, ultimately contributing to improved patient quality of life and outcomes. Overall, the US Atherectomy Devices Market segmentation exhibits a dynamic landscape where each device type contributes distinctly to market growth and reflects the evolving technology and treatment paradigms in the realm of vascular interventions.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The US Atherectomy Devices Market is significantly influenced by various applications, including Coronary Artery Disease, Peripheral Artery Disease, and Carotid Artery Disease. Coronary Artery Disease, being one of the leading causes of mortality in the United States, drives innovation and demand for atherectomy devices, as they provide minimally invasive solutions to remove plaque build-up in the coronary arteries. Peripheral Artery Disease is on the rise, often associated with aging demographics and lifestyle diseases, making it crucial to improve the treatment landscape and enhance patient quality of life.
Meanwhile, Carotid Artery Disease presents a significant concern due to its association with stroke risk; thus, the effectiveness of atherectomy procedures can significantly impact patient outcomes. The increasing prevalence of these conditions is coupled with advancements in technology, which present opportunities for improved procedural success and patient safety. Continuous Research and Development in atherectomy devices aim to enhance their efficacy and adopt new materials and techniques, addressing ongoing challenges such as device-related complications and efficacy discrepancies across demographics. The US Atherectomy Devices Market segmentation reflects a focused approach towards addressing these health concerns, making it an important sector in cardiovascular care.
The US Atherectomy Devices Market is significantly driven by the End User segment, which incorporates various healthcare settings including Hospitals, Cardiac Catheterization Labs, and Ambulatory Surgical Centers. Hospitals are essential in this market as they serve a vast patient population and often have the most advanced medical technology and specialists available, enabling effective treatment procedures using atherectomy devices. Cardiac Catheterization Labs play a crucial role in the diagnosis and treatment of cardiovascular diseases, making them an important environment for atherectomy procedures; the increasing prevalence of coronary artery diseases further supports the growth of this segment.
Ambulatory Surgical Centers are gaining traction due to their ability to provide outpatient procedures, thus offering patients a less invasive option with quicker recovery times, which is becoming increasingly preferred in the healthcare industry. The amalgamation of these facilities contributes to the overall efficiency in managing cardiovascular diseases in the US, highlighting their significance in the US Atherectomy Devices Market revenue. As trends shift towards minimally invasive procedures, the demand for atherectomy devices is anticipated to rise, providing ample opportunities for growth within these End User categories. The ability of these facilities to adopt innovative technologies while meeting regulatory standards reinforces their pivotal role in this market landscape.
The US Atherectomy Devices Market is significantly influenced by the choice of materials used in device manufacturing, which include Stainless Steel, Polymers, and Composites. Stainless Steel has long been a preferred choice due to its strength and durability, ensuring reliability during surgical procedures. Polymers are gaining traction for their flexibility and lightweight properties, making them suitable for various applications in minimally invasive surgeries. Composites combine the benefits of both metal and plastic, often optimizing performance while reducing weight, which is increasingly important in the development of next-generation atherectomy devices.
Each material segment plays a crucial role in driving innovation and enhancing patient outcomes, as manufacturers strive to meet the evolving needs of healthcare professionals and patients in the US. The diversity in material selection fosters advancements in design and functionality, fueling market growth and expanding opportunities within the US Atherectomy Devices Market. Overall, the market segmentation based on Material highlights the essential characteristics that contribute to the effectiveness of atherectomy procedures while responding to the growing demands within the healthcare sector.
The US Atherectomy Devices Market is characterized by intense competition among key players who focus on innovation and the development of advanced technologies to improve the treatment of cardiovascular diseases. The market comprises a variety of devices designed to remove atherosclerotic plaque from blood vessels, ensuring better outcomes for patients suffering from peripheral and coronary artery diseases. As the prevalence of these conditions increases, driven by factors such as an aging population and rising obesity rates, competition has prompted manufacturers to expand product portfolios and optimize their offerings. Strategic partnerships, collaborations, and mergers are common practices among established and emerging companies looking to enhance their market presence.
Furthermore, regulatory approvals and the introduction of cutting-edge technologies such as laser and directional atherectomy are reshaping market dynamics, allowing for more effective treatment solutions that encourage patient recovery and satisfaction. Eagle Medical has made a significant mark in the US Atherectomy Devices Market through its commitment to delivering innovative products and solutions that address critical healthcare needs. The company's strength lies in its robust research and development capabilities, enabling it to create advanced atherectomy devices that cater specifically to the requirements of medical professionals and patients. With a strong emphasis on product quality and efficiency, Eagle Medical has built a reputation for reliability and high performance in medical devices.
The company's strategic focus on maintaining strong relationships with healthcare providers has allowed it to establish a solid market presence across various regions in the United States, ensuring that its products are accessible where they are needed most. SentreHEART is recognized as a key player in the US Atherectomy Devices Market, leveraging its robust technology portfolio to develop solutions that enhance patient outcomes in cardiovascular care. The company offers a range of innovative products, with a particular emphasis on devices designed for the treatment of complex vascular challenges. SentreHEART's strengths lie in its ability to integrate cutting-edge technology with clinical expertise, fostering trust among healthcare professionals. The company has strategically pursued mergers and acquisitions to enhance its product offerings and expand its market foothold, strengthening its competitive edge. This strategic growth allows SentreHEART to provide comprehensive solutions aligned with the evolving needs of the healthcare industry, ensuring that it remains at the forefront of advancements in atherectomy technology within the US market.
The US Atherectomy Devices Market has recently seen significant developments, including increased investment in innovative technologies and clinical advancements. Companies like Medtronic, Abbott Laboratories, and Boston Scientific are at the forefront, with ongoing Research and Development initiatives aimed at enhancing the efficacy of their atherectomy devices. The market is experiencing growth due to rising incidences of cardiovascular diseases, with the US Centers for Disease Control and Prevention emphasizing the need for advanced treatment options. In terms of mergers and acquisitions, there have been notable movements in the market. In June 2023, Boston Scientific announced its acquisition of an innovative atherectomy technology company, further solidifying its market position.
Additionally, in March 2022, Cardiovascular Systems acquired the rights to a new device, expanding its product portfolio. Over the past few years, major regulatory approvals have also been granted, allowing for a broader range of treatment options for patients suffering from peripheral artery disease. As a result, the market valuation for atherectomy devices in the US is on the rise, positively impacting the competitive landscape and expanding accessibility for patients in need of these critical medical interventions.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 409.15(USD Million) |
| MARKET SIZE 2024 | 428.65(USD Million) |
| MARKET SIZE 2035 | 700.17(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.562% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Eagle Medical, SentreHEART, Medtronic, Abbott Laboratories, Boston Scientific, Avinger, Cardiovascular Systems, Cordis, Spectranetics, Terumo, AngioDynamics, Philips, Johnson and Johnson, Asahi Intecc |
| SEGMENTS COVERED | Type, Application, End User, Material |
| KEY MARKET OPPORTUNITIES | Technological advancements in devices, Rising incidence of cardiovascular diseases, Increasing adoption of minimally invasive procedures, Growing geriatric population, Expansion of outpatient surgical centers |
| KEY MARKET DYNAMICS | Increasing prevalence of cardiovascular diseases, Advancements in minimally invasive procedures, Growing geriatric population, Rising preference for outpatient procedures, Technological innovations in device design |
| COUNTRIES COVERED | US |
Frequently Asked Questions (FAQ) :
The US Atherectomy Devices Market is expected to be valued at 428.65 million USD in 2024.
By 2035, the US Atherectomy Devices Market is projected to reach a value of 700.17 million USD.
The expected CAGR for the US Atherectomy Devices Market from 2025 to 2035 is 4.562%.
By 2035, rotational atherectomy devices are anticipated to hold a significant market share, valued at 264.67 million USD.
Directional atherectomy devices are expected to have a market value of 140.5 million USD in 2035.
Major players in the US Atherectomy Devices Market include Medtronic, Abbott Laboratories, Boston Scientific, and Cordis among others.
The market size for laser atherectomy devices is expected to be 120.0 million USD in 2024.
The US Atherectomy Devices Market serves various applications in cardiovascular procedures aimed at treating arterial blockages.
Key growth drivers for the US Atherectomy Devices Market include technological advancements and increasing prevalence of cardiovascular diseases.
By 2035, the market value for orbital atherectomy devices is projected to reach 95.0 million USD.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
